Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jennifer Maschmann

Obstetrics & Gynecology Spring Valley, IL Medical Doctor

NPI 1023021433 CMS profile 478066

600 E 1St St, Spring Valley, IL 61362

Open in the dashboard

General payments

$1,971

53 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jennifer Maschmann of Spring Valley, IL is reported in the CMS Open Payments database as having received $1,971 across 53 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $931 5
2024 General $88 2
2023 General $42 2
2022 General $247 9
2021 General $203 10
2020 General $131 4
2019 General $330 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Maschmann
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Jennifer Maschmann were reported at $931. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Jennifer Maschmann Obstetrics & Gynecology median Middle half National median
2019 $330 $172 $62–$391 $163
2020 $131 $94 $36–$222 $114
2021 $203 $136 $42–$369 $132
2022 $247 $160 $50–$433 $149
2023 $42 $169 $56–$423 $160
2024 $88 $152 $50–$371 $164
2025 $931 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $931 5 payments
  2. AbbVie, Inc. $560 28 payments
  3. Astellas Pharma US Inc $177 3 payments
  4. Roche Diagnostics Corporation $65 4 payments
  5. Bayer HealthCare Pharmaceuticals Inc. $61 3 payments
  6. TherapeuticsMD, Inc. $47 3 payments
  7. Exeltis, USA Inc. $25 1 payment
  8. Hologic, LLC $22 1 payment
  9. Pfizer Inc. $20 1 payment
  10. Amgen Inc. $18 1 payment
  11. Other $45 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,240 49 payments
  2. Travel and Lodging $646 3 payments
  3. Education $85 1 payment
Products named General payments · program years 2019–2025
  1. Solyx SIS System $803 4 payments
  2. ORIAHNN $219 10 payments
  3. ORILISSA Womens Health $217 9 payments
  4. Orilissa Endocrinology $188 12 payments
  5. Solyx Blue $128 1 payment
  6. LO LOESTRIN FE $108 7 payments
  7. Veozah $71 1 payment
  8. IMVEXXY $47 3 payments
  9. Kyleena $33 2 payments
  10. Mirena $33 2 payments
  11. Other $348 18 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

88

Median for Obstetrics & Gynecology: 65

Drug cost

$2,661

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

20.5%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Estradiol Generic 56 $2,400
Sprintec Norgestimate-Ethinyl Estradiol Brand 18 $180
Zolpidem Tartrate Generic 14 $82

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Records

53 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record